carnosine has been researched along with Hematologic Malignancies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H; Itoh, Y; Kasahara, S; Kato-Hayashi, H; Kitagawa, J; Kobayashi, R; Nagata, Y; Ohata, K; Ono, T; Sawada, M; Shimizu, M; Suzuki, A; Tsurumi, H | 1 |
| Endo-Ohnishi, S; Fukao, T; Funato, M; Ishihara, M; Itoh, Y; Kobayashi, R; Nozawa, A; Ozeki, M; Suzuki, A; Yasue, S | 1 |
| Hara, T; Hayashi, H; Ishihara, M; Itoh, Y; Kanemura, N; Kasahara, S; Kitagawa, J; Kitaichi, K; Kobayashi, R; Moriwaki, H; Nakamura, N; Suzuki, A; Tsurumi, H | 1 |
| Hayashi, H; Ishida, M; Itoh, Y; Kitagawa, J; Kobayashi, R; Shakui, T; Sugiyama, T; Suzuki, A; Takeuchi, H; Tsurumi, H; Yamada, Y | 1 |
1 trial(s) available for carnosine and Hematologic Malignancies
| Article | Year |
|---|---|
Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi-institutional randomized controlled trial.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antineoplastic Agents; Carnosine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organometallic Compounds; Stomatitis; Transplantation Conditioning; Young Adult; Zinc Compounds | 2021 |
3 other study(ies) available for carnosine and Hematologic Malignancies
| Article | Year |
|---|---|
Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
Topics: Adolescent; Antineoplastic Agents; Carnosine; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Organometallic Compounds; Retrospective Studies; Stomatitis; Transplantation, Autologous; Zinc; Zinc Compounds | 2018 |
Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antineoplastic Agents; Carnosine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mouth Mucosa; Organometallic Compounds; Pain Management; Retrospective Studies; Stomatitis; Taste; Young Adult; Zinc Compounds | 2014 |
Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy.
Topics: Adult; Aged; Anti-Ulcer Agents; Antineoplastic Agents; Carnosine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organometallic Compounds; Stomatitis; Tablets; Transplantation Conditioning; Young Adult; Zinc Compounds | 2016 |